MedTrace Logo

Effect of #LIFEGOALS on Adolescents' Mental Health

NCT04719858 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 375

Last updated 2021-11-22

No results posted yet for this study

Summary

The aim of this study is to evaluate the effectiveness of the #LIFEGOALS intervention for promoting mental health in early adolescents.

Conditions

  • Well-being
  • Life Style, Healthy
  • Resilience
  • Depressive Symptoms

Interventions

BEHAVIORAL

#LIFEGOALS

Digital health behaviour change intervention including: 1. self-regulation component with Fitbit: goal setting, monitoring, feedback; 2. narrative component: every week participants receive a new episode (2-5 minutes) of a youth series modeling the target behaviours; 3. chatbot component: automated virtual coach that will send encouraging messages and give an automated answer to user questions. Participants install the #LIFEGOALS app on their own mobile phone and are asked to use the app during 12 consecutive weeks. Three times per week a notification will be sent to encourage engagement with the intervention.

Sponsors & Collaborators

  • Agentschap Zorg en Gezondheid, Belgium

    collaborator UNKNOWN

  • Vlaams Instituut Gezond Leven VZW

    collaborator UNKNOWN

  • Research Foundation Flanders

    collaborator OTHER

  • University Ghent

    lead OTHER

Principal Investigators

  • Greet Cardon, Prof · University Ghent

  • Geert Crombez, Prof · University Ghent

  • Ann DeSmet, PhD · Université Libre de Bruxelles

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-20
Primary Completion
2021-05-31
Completion
2021-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04719858 on ClinicalTrials.gov